Zobrazeno 1 - 10
of 1 142
pro vyhledávání: '"S, Georgiev"'
Publikováno v:
Journal of High Energy Physics, Vol 2024, Iss 8, Pp 1-37 (2024)
Abstract Fibonacci anyons ε provide the simplest possible model of non-Abelian fusion rules: [1] × [1] = [0] ⊕ [1]. We propose a conformal field theory construction of topological quantum registers based on Fibonacci anyons realized as quasiparti
Externí odkaz:
https://doaj.org/article/0904148377b741ba8eb0e1d2ae69ac12
Autor:
Ivan V. Kuzmin, Ruben Soto Acosta, Layne Pruitt, Perry T. Wasdin, Kritika Kedarinath, Keziah R. Hernandez, Kristyn A. Gonzales, Kharighan Hill, Nicole G. Weidner, Chad Mire, Taylor B. Engdahl, Woohyun J. Moon, Vsevolod Popov, James E. Crowe, Ivelin S. Georgiev, Mariano A. Garcia-Blanco, Robert K. Abbott, Alexander Bukreyev
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-18 (2024)
Abstract The rodent-borne Andes virus (ANDV) causes a severe disease in humans. We developed an ANDV mRNA vaccine based on the M segment of the viral genome, either with regular uridine (U-mRNA) or N1-methylpseudouridine (m1Ψ-mRNA). Female mice immu
Externí odkaz:
https://doaj.org/article/b9d9f5258a8943afbcc90d9e051b9c63
Autor:
Kevin J. Kramer, Erin M. Wilfong, Kelsey Voss, Sierra M. Barone, Andrea R. Shiakolas, Nagarajan Raju, Caroline E. Roe, Naveenchandra Suryadevara, Lauren M. Walker, Steven C. Wall, Ariana Paulo, Samuel Schaefer, Debolanle Dahunsi, Camille S. Westlake, James E. Crowe, Robert H. Carnahan, Jeffrey C. Rathmell, Rachel H. Bonami, Ivelin S. Georgiev, Jonathan M. Irish
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-20 (2022)
Vaccination against COVID-19 has shown activation of different immune cell types. Here the authors characterise the immune response to the SARS-CoV-2 mRNA vaccine using longitudinal CyTOF single cell approaches to characterise antigen specific B and
Externí odkaz:
https://doaj.org/article/54f0d07dda6a4419baae2ec37e6174d0
Autor:
Kelsey A. Pilewski, Steven Wall, Simone I. Richardson, Nelia P. Manamela, Kaitlyn Clark, Tandile Hermanus, Elad Binshtein, Rohit Venkat, Giuseppe A. Sautto, Kevin J. Kramer, Andrea R. Shiakolas, Ian Setliff, Jordan Salas, Rutendo E. Mapengo, Naveen Suryadevara, John R. Brannon, Connor J. Beebout, Rob Parks, Nagarajan Raju, Nicole Frumento, Lauren M. Walker, Emilee Friedman Fechter, Juliana S. Qin, Amyn A. Murji, Katarzyna Janowska, Bhishem Thakur, Jared Lindenberger, Aaron J. May, Xiao Huang, Salam Sammour, Priyamvada Acharya, Robert H. Carnahan, Ted M. Ross, Barton F. Haynes, Maria Hadjifrangiskou, James E. Crowe, Jr., Justin R. Bailey, Spyros Kalams, Lynn Morris, Ivelin S. Georgiev
Publikováno v:
Cell Reports, Vol 42, Iss 2, Pp 112044- (2023)
Summary: Despite prolific efforts to characterize the antibody response to human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) mono-infections, the response to chronic co-infection with these two ever-evolving viruses is poorly un
Externí odkaz:
https://doaj.org/article/1510f5933b314ee292c1c7de93695a93
Autor:
Naveenchandra Suryadevara, Andrea R. Shiakolas, Laura A. VanBlargan, Elad Binshtein, Rita E. Chen, James Brett Case, Kevin J. Kramer, Erica C. Armstrong, Luke Myers, Andrew Trivette, Christopher Gainza, Rachel S. Nargi, Christopher N. Selverian, Edgar Davidson, Benjamin J. Doranz, Summer M. Diaz, Laura S. Handal, Robert H. Carnahan, Michael S. Diamond, Ivelin S. Georgiev, James E. Crowe Jr.
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 11 (2022)
The protective human antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) focuses on the spike (S) protein, which decorates the virion surface and mediates cell binding and entry. Most SARS-CoV-2 protective antibodies tar
Externí odkaz:
https://doaj.org/article/9fba5e9f15e74bbdb3531fad2680cb32
Autor:
Lauren M. Walker, Andrea R. Shiakolas, Rohit Venkat, Zhaojing Ariel Liu, Steven Wall, Nagarajan Raju, Kelsey A. Pilewski, Ian Setliff, Amyn A. Murji, Rebecca Gillespie, Nigel A. Makoah, Masaru Kanekiyo, Mark Connors, Lynn Morris, Ivelin S. Georgiev
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Development of novel technologies for the discovery of human monoclonal antibodies has proven invaluable in the fight against infectious diseases. Among the diverse antibody repertoires elicited by infection or vaccination, often only rare antibodies
Externí odkaz:
https://doaj.org/article/b4cc54924c22433d9477b4b78981ae3b
Autor:
Amyn A. Murji, Nagarajan Raju, Juliana S. Qin, Haajira Kaldine, Katarzyna Janowska, Emilee Friedman Fechter, Rutendo Mapengo, Cathrine Scheepers, Ian Setliff, Priyamvada Acharya, Lynn Morris, Ivelin S. Georgiev
Publikováno v:
iScience, Vol 25, Iss 1, Pp 103564- (2022)
Summary: Public antibody clonotypes shared among multiple individuals have been identified for several pathogens. However, little is known about the determinants of antibody “publicness”. Here, we characterize the sequence and functional properti
Externí odkaz:
https://doaj.org/article/7e7b5f1f1ab5440fa14d766fce6c0ff0
Autor:
M. Gordon Joyce, Amy Bao, Man Chen, Ivelin S. Georgiev, Li Ou, Tatsiana Bylund, Aliaksandr Druz, Wing-Pui Kong, Dongjun Peng, Emily J. Rundlet, Joseph G. Van Galen, Shuishu Wang, Yongping Yang, Baoshan Zhang, Gwo-Yu Chuang, Jason S. McLellan, Barney S. Graham, John R. Mascola, Peter D. Kwong
Publikováno v:
Pathogens and Immunity, Vol 4, Iss 2, Pp 294-323 (2019)
Background: Respiratory syncytial virus (RSV) subtypes, A and B, co-circulate in annual epidemics and alternate in dominance. We have shown that a subtype A RSV fusion (F) glycoprotein, stabilized in its prefusion conformation by DS-Cav1 mutations, i
Externí odkaz:
https://doaj.org/article/aa9225bfc40c4f49a0f6918637f4fc7d
Autor:
Tinashe E. Nyanhete, Robert J. Edwards, Celia C. LaBranche, Katayoun Mansouri, Amanda Eaton, S. Moses Dennison, Kevin O. Saunders, Derrick Goodman, Katarzyna Janowska, Rachel L. Spreng, Lu Zhang, Sarah V. Mudrak, Thomas J. Hope, Bhavna Hora, Todd Bradley, Ivelin S. Georgiev, David C. Montefiori, Priyamvada Acharya, Georgia D. Tomaras
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Broadly neutralizing antibodies (bNAbs), known to mediate immune control of HIV-1 infection, only develop in a small subset of HIV-1 infected individuals. Despite being traditionally associated with patients with high viral loads, bNAbs have also bee
Externí odkaz:
https://doaj.org/article/4c61ef5241d443e0b0ae4ef0bd8e6785
Autor:
Kevin J. Kramer, Nicole V. Johnson, Andrea R. Shiakolas, Naveenchandra Suryadevara, Sivakumar Periasamy, Nagarajan Raju, Jazmean K. Williams, Daniel Wrapp, Seth J. Zost, Lauren M. Walker, Steven C. Wall, Clinton M. Holt, Ching-Lin Hsieh, Rachel E. Sutton, Ariana Paulo, Rachel S. Nargi, Edgar Davidson, Benjamin J. Doranz, James E. Crowe, Jr., Alexander Bukreyev, Robert H. Carnahan, Jason S. McLellan, Ivelin S. Georgiev
Publikováno v:
Cell Reports, Vol 37, Iss 1, Pp 109784- (2021)
Summary: The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages that are more transmissible and resistant to currently approved antibody therapies poses a considerable challenge to the clinical treatment of coronavirus
Externí odkaz:
https://doaj.org/article/f0d8cdf7656645d0b29756b1b1c69e65